Lantern Pharma Inc.
About
3.59USD+0.09 +2.57%
Closed • Updated at 06:52 GMT+00:00Market Cap$40.58M
Volume116.5K
Beta4.06
RSI71.16
Lantern Pharma Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 19 2026
Lantern Pharma Announces Successful Outcome of FDA Type C Meeting Request for HARMONIC™ Phase 2 Trial of LP-300 in Never-Smokers with NSCLC
May 15 2026
Lantern Pharma Reports First Quarter 2026 Financial Results and Provides Business Updates
May 14 2026
Lantern Pharma Inc. Announces Closing of up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
May 13 2026
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
May 11 2026
Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026
Community Chat
Ask AI
Try asking